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Dental implant is one of the restorative methods to replace missing teeth. As implants are directly 
anchored into bones, they provide stability, a more natural appearance, and minimize the risk of bone 
resorption and atrophy. However, studies found that diabetes mellitus patients had a slower healing 
process after surgery because of the reduction of vascular supply due to microangiopathies, decreased 
host defense, formation of advanced glycation end-products (AGEs), reduction of collagen production 
and increased collagenase activity. Diabetes mellitus patients may pose contraindications to dental 
implants. As a result of that, dental implantation failure rate in diabetic patients is much higher than that 
in non-diabetic patients. In this clinical experiment, we compared the amount of blood cells, and 
cytokines production 24 h post implantations, and the implant mobility 90 days post-surgery between 
controlled type 2 diabetic patients and the non-diabetic patients. It was aimed to investigate the 
suitability of diabetic patients to have dental implants and the efficacy of the amount of dental implants 
related to the success rates. 138 patients with type 2 diabetics and 140 healthy subjects, who had one 
to three adjacent edentulous spaces, were selected. Dental implantation surgeries were performed 
under local anesthesia. Wounds were sutured and all subjects were given 0.2% chlorohexidine 
mouthwash for 14 days. Complete blood picture and cytokines production were assayed before 
operation, as well as on days 1, 2, and 5 after implantation. Implant mobility and periodontal wound 
healing were monitored once in a fortnight up to 90 days. There were no statistically significant 
differences in the production of cytokines. In 138 diabetic patients, 255 implants were presented with 
second degree mobility 90 days after surgery while the same was demonstrated in 48 out of 346 
implants from the healthy subjects. These implants were considered failures and were extracted. 
Implant failure in diabetics was significantly greater than that in non-diabetics when multiple adjoining 
implants were placed.  
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INTRODUCTION 
 
According to the World Health Organization, more than 
180 million people worldwide are suffering from diabetes 
mellitus, one of the most common health problems in the 
world, while the number of diabetes sufferers is mounting 
to a  double  by  2030  (Chalmers et al., 2008).  Diabetes  
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mellitus is a chronic disease,  which  occurs  when  blood 
glucose concentration in body is in excess (Bianchi et al., 
2008). This happens usually when the production of in-
sulin, a hormone essential to regulate blood glucose level, 
from pancreas is inadequate, or when the body cannot 
effectively use the insulin it produces. Diabetes mellitus is 
characterized by hyperglycemia and glucose intolerance 
(Fonseca, 2007). The disorder, hyperglycemia, is used to 
describe the increased concentration of glucose in the 
blood while glucose intolerance is associated with  insulin  
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Table 1. Characteristics of the diabetic patients. 
 
Parameters Patients number and references values (n=138) 
Mean age 45.5 years (range: 38-50 years) 
<40 years 67 
>40 years 71 
Female 47 
Male 91 
Type of diabetes                                     II
Hypertension (mmHg) Mean: 152/95 (+/-: 6/2.5) 
Body weight (kg) Mean:82.5(+/-:10.5) 
Body height(m) 1.57(+/-:1.2) 
Body mass index (kg/m2) (29+/-:4.46) 
 
 
 
resistance. Among diabetes, there are mainly two types 
of idiopathic diabetes, type 1 and type 2 diabetes. Type 1 
diabetes, previously known as insulin-dependent or 
childhood-onset diabetes, is characterized by a lack of 
insulin production. Type 2 diabetes, formerly called non-
insulin-dependent or adult-onset diabetes, is caused by 
the body’s ineffective use of insulin. It often results from 
excess body weight and physical inactivity. As a result of 
diabetes mellitus, it affects the blood circulations and is 
associated with many complications such as cardio-
vascular diseases, particularly heart attack and stroke 
(Aronson, 2008; Bianchi et al., 2008). Furthermore, it is 
found that diabetes also reduces healing of wounds 
(Chaudhary et al., 2008), bones (Kotsovilis et al., 2006) 
and has been considered to contribute to failure in one of 
the dental restoration method-dental implant (Kotsovilis et 
al., 2006). 
Dental implant is one of the dental restorative methods 
to replace missing teeth. As implants are directly an-
chored into bones, they provide stability to the new teeth, 
a more natural appearance, and minimizes the risk of 
bone resportion and atrophy, in contrast to other 
traditional restoration methods (Balshi and Wolfinger, 
1999). Dental implant is therefore becoming more popu-
lar these days. It involves osseointegration as well as 
periodontal wound healing. Studies found that diabetes 
mellitus patients had a slower healing process after 
surgery, and therefore would expose the tissues to com-
plications such as tissue necrosis (Rothwell and Richard, 
1984; Balshi and Wolfinger, 1999). Moreover, animal 
studies indicated that streptozotocin-induced diabetes 
interfered with the process of osseointegration (Shernoff 
et al., 1994; Balshi and Wolfinger, 1997; Balshi and 
Wolfinger, 1999). Wound healing involves migration, ad-
hesion, proliferation, and differentiation of several cell 
types (Grzesik et al., 2002). Diabetes mellitus will there-
fore cause a slower healing process because of the 
reduction of vascular supply due to microangiopathies, 
decreasing of host defense, formation of advanced 
glycation end-products (AGEs), reduction of collagen 
production and increased collagenase activity (Fiorellini 
and Nevins, 2000; Kotsovilis et al., 2006). Because of 
these unwanted effects, diabetes mellitus patients have 
possible contraindications to dental implants (Park, 2007). 
Dental implantation failure rate in diabetic patients is 
much higher than that in non-diabetic patients. In this 
experiment, we compared the amount of blood cells, and 
cytokines production 24 h post implantations, and the im-
plant mobility 12 weeks post-surgery between type 2 dia-
betic patients and the non-diabetic patients. It was aimed 
to investigate the suitability of diabetic patients to have 
dental implants and the number of dental implants related 
to the success rates. 
 
 
MATERIALS AND METHODS  
 
Subject selections 
 
From 2005 to 2007, two-hundred-and-eight patients who had dental 
implants were selected. The ethics committees at Sichuan Univer-
sity and Hospital of Stomatology approved the research protocols 
(reference number: 05JY029-023-3), with informed consent being 
obtained from these patients before joining the study. The selection 
criterion of patients was to have one to three adjacent edentulous 
spaces which presented at least one year before the study. A total 
of 278 subjects was divided into two groups, the diabetes group 
and the control group. The diabetes group consisted of 138 diabetic 
patients, 95 females and 43 males with an average age of 45.5, 
ranging from 38 to 50 (Table 1). The control group consisted of 140 
patients, 64 females and 76 males, of which they were non-diabetic 
patients. Patients in the diabetic group were all diagnosed with type 
2 diabetes and had been taking metformin 1000 mg BID mono-
therapy for at least one year, with a mean fasting serum glucose of 
7.6 mmol/l (Table 2) and BMI of 29 kg/m2 (Table 1). All subjects 
were observed over a period of 90 days. 
 
 
Pre-operative preparations 
 
Before dental implantations, pre-operative preparations were done. 
Conventional X-Ray and panoramic autograph were employed to 
check for the height of the alveolar bone and the bone density of 
patients. Patients consumed preventive oral antibiotic one day be-
fore the surgery to prevent inflammations caused by pathogenic 
bacteria. Right before the surgery, patients had mouthwash with 
0.12% chlorine for three times. Blood samples were drawn  from  all  
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Table 2. Cytokines expression in two groups of dental implant patients. 
 
Cytokines / Time points Control group Diabetes group Std. deviation P -value 
**Before OT 27.1818 37.5843 11.48430 0.840 
Day 1 24.7273 31.7994 10.52702 0.808 
Day 2 26.0000 34.8107 11.11488 0.890 
IL2 
Day 5 24.0000 29.7947 8.62554 0.812 
Before OT 41.0191 48.1771 10.65488 0.545 
Day 1 45.4623 53.0605 11.31005 0.703 
Day 2 47.3927 61.6499 11.22212 0.723 
IL6 
Day 5 43.7473 51.2029 11.09782 0.684 
Before OT 60.5964 65.9515 7.97112 0.305 
Day 1 65.3677 80.2124 12.09657 0.58 
Day 2 65.7449 81.9706 14.15232 0.505 
TNF 
Day 5 67.2144 83.4935 14.23184 0.553 
*C-Reactive protein (mg/l) Day 1 0.8 (+/- 0.23) 4.5 (+/- 1.45) 6.459 0.012 
 
*C-Reactive Protein(High Sensitivity: normally <3 mg/l). 
**Before OT (one day prior to operation). 
 
 
 
subjects to have the biochemical tests run by COBAS, INTEGRA 
400 (Roche, Germany) (Table 2). 
 
 
Dental implantations 
 
Dental implantation surgeries were performed under local ane-
sthesia (2% xylestesin-A) using ITI implant system (Straumann 
Company, Switzerland). All implants had ITI neck plus implants, the 
diameter of implant body was 3.3 mm, and the diameter of implant 
neck was 3.5 mm. The incision was made on the alveolar crest and 
relieve incision was made on the mesio-distal side to expose the 
bone over the site of the implant. A full thickness flap was elevated. 
The area of incision was 2-3 mm larger than the titanium membrane. 
Then a special drill, with water passing through its center, was used 
to prepare the bone site. The implant was screwed and twisted into 
place. Soft tissue wounds were sutured and all patients were given 
prophylactic amoxicillin 1 g QD and acetaminophen 500 mg BID, 
which have been shown to prevent bacterial infections (Ottaviani et 
al., 1989) and relieve inflammation and pain (Guindon et al., 2007), 
for one week after surgery. Besides, patients were given 0.2% chlo-
rohexidine mouthwash for 14 days after surgery to prevent bacterial 
growth. Diabetic patients continued anti-glycemic medication 
throughout the study.  
 
 
Post-operative measurements  
 
After dental implants were placed, blood was drawn from all 
patients 24 h after the surgery for the assay on complete blood 
picture using KX-21N (SYSMEX, Japan). The serum level of 
cytokines of IL2, IL6, and IFN  were measured by R & D ELISA kit 
(R & D Systems, Minneapolis, USA) before operation, as well as on 
days 1, 2, and 5. For the serum extracted from patients’ blood, 100 
µl of the serum was pipetted into a 96 wells plate to be incubated 
for 75 min at 350 rpm and washed with washing buffer for three 
times. The wells were dried and read at 450 nm wavelength using 
Universal Microplate Reader (Sunrise, Tecan Co., Grödingen, 
Austria). The levels of cytokines in the samples were obtained by 
comparison with the standard curve generated from standards sup-
plied by the manufacture. Each sample was analysed in triplicates. 
The  production  levels  of  cytokines  before  and  after  the  dental  
implants were compared. 
 
 
Implants mobility 
 
Follow up measurements included investigation on implant mobility 
and periodontal wound healing were performed every 14 days after 
surgery for 90 days. Implant mobility was expressed as Io or IIo. The 
number of teeth integrated into bone was recorded for each subject. 
A maximum of three implants were allowed in an adjacent eden-
tulous space while multiple implantations could be integrated in 
different dental sites for each subject.  
 
 
Statistical analysis 
 
The cytokine expression, biochemical parameters and complete 
blood counts were analysed by student t-test in SPSS 15.0 (SPSS 
Inc., USA).  
 
 
RESULTS 
 
Biochemical parameters in blood before dental 
implants 
 
Among all biochemical parameters in serum tested, most 
of the average parameter levels had shown no significant 
differences between the control and diabetes group 
except for glucose during fasting (Table 2). For diabetes 
group, the average glucose level during fasting was signi-
ficantly higher (p<0.05) than the levels of the control 
group (Table 2). 
 
 
Cytokine production and complete blood picture 24 h 
after surgery 
 
For the control group, the average production of IL-2  was  
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Table 3. The biochemical parameters in serum of two groups of subjects. 
 
Parameters Control group (n=70) Diabetes group (n=138) Unit Normal Range 
Urea 7.2.0(+/- 2.1) 8.0(+/- 1.67) mmol/L <11.9 
Creatine 63.2(+/- 11.2) 78.6(+/- 9.78) umol/L 44-106 
Chloride 102(+/- 3.2) 104(+/- 4.5) mmol/L 100-117 
Postassium 3.52(+/- 1.03) 3.98(+/- 0.6) mmol/L 3.6-5.0 
Sodium 138.65(+/- 3.4) 142(+/- 4.35) mmol/L 134-148 
*Glucose (Fasting) 5.01(+/- 0.35) 7.2(+/- 2.4) mmol/L <6 
Hemoglobin A1c 4.5(+/- 0.5) 8.5(+/- 1.25) % <5.9% (NGSP) 
High density lipoproteins 2.0(+/- 0.25) 1.36(+/- 0.16) mmol/L Females>1.68; Males>1.45 
*Low density lipoproteins 2.89(+/- 0.86) 4.31(+/- 0.45) mmol/L <2.59 
Triglycerides 0.85(+/- 0.15) 1.96(+/- 0.56) mmol/L <2.3 
 
*Indicated statistical significance between control and diabetes groups p<0.05. 
Data were presented as mean±95% confidence interval (95% CI). 
 
 
 
Table 4. Complete blood picture on two groups of subject 24 hours after implantation on  
 
Parameters Control group ( n=70) Diabetes group (n=138) Unit Normal range 
White blood cell 6.0(+/- 2.5) *10.3(+/- 2.35) x109/L 4.00-11.00 
 Lymphocytes 1.8(+/- 0.57) *3.0(+/- 0.5) x109/L 1.50-4.00 
Middle cells: (eosinophils, basophils, monocytes) 0.2(+/- 0.05) 0.8(+/- 0.2) x109/L 0.2-1.30 
Neutrophils 3.0(+/- 0.25) *5.8(+/- 0.96) x109/L 2.0-7.5 
Red blood cell 4.0(+/- 1.5) 3.84(+/- 0.8) x1012/L 3.8-5.80 
Hemoglobin 12.5(+/- 1.5) 13.6(+/- 0.95) g/dL 11.5-16.5 
Platelet 188(+/- 35) 235(+/- 17) x109/L 150-400 
 
*Compared control and diabetes group (p<0.05) showed statistical significant. 
Data were presented as mean±95% confidence interval (95% CI). 
 
 
 
decreased while the production of IL-6 and TNF- were 
increased 24 h after implants (Table 3). For test group, 
patients with diabetes mellitus, increased production of 
IL-2, IL-6 and TNF- were measured 24 h the implants 
(Table 3). There was no statistical significance among 
those cytokines between the groups. White blood cells 
(WBC), lymphocytes and neutrophils levels were signifi-
cantly higher (p<0.05) in diabetes group than that 
measured in the control group 24 h post-implantations 
(Table 4). 
 
 
Mobility of dental implants 
 
There were 255 dental implants placed in 138 patients 
with type II diabetes. 174 implants (68%) presented with 
second degree mobility at 90 days after surgery, at which 
point, these implants were considered failures and were 
extracted (Table 5). Eighty-one implants (32%) were inte-
grated into bone with first degree mobility, at which point, 
these implants were considered as successful. In control 
group, 48 implants out of the 346 (14%) have failed and 
298 implants were successfully retained into bone with 
periodontal healing. There was statistical significance 
between the two groups on both success and failure rate 
(X2: 89.638, p < 0.05). Within the diabetic patients group, 
all patients with three adjacent implants failed. 31 out of 
72 cases with two implants failed where as only 25% 
cases with one implant failed. 
 
 
DISCUSSION 
 
Despite the well controlled serum glucose levels on dia-
betic patients, no significant enhancement was shown in 
the successful rates of dental implants. As indicated from 
the experiment, type 2 diabetic patients had a signifi-
cantly less successful rate of dental implants than that of 
non-diabetic patients. It was consistent with similar 
research results that diabetes mellitus patients had a 
higher risk of dental implant failure (Mellado-Valero et al., 
2007; Scully et al., 2007; Klokkevold and Han, 2008). 
Type 2 diabetic patients demonstrated a higher mean 
level of WBC, lymphocyte, and neutrophil counts than 
those of the non-diabetic patients 24 h after implant 
placement. It was revealed that diabetes mellitus induced 
acute inflammation after dental implants and contributed 
instability to teeth  replacement. For  cytokine  production  
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Table 5. Implant mobility of two groups 90 days after dental implants. 
 
Control Group (n= 346) Diabetes Group (n= 255) Degree of mobility 
Number of mobile implants Percentage Number of mobile implants Percentage 
0-Io Mobility 298/346 86% *81/255 32% 
IIo Mobility 48/346 14% *174/255 68% 
 
*Compared control and diabetes group (p<0.05) showed statistical significant. 
 
 
 
24 h after surgery, IL-2 level was decreased in the dia-
betes group while IL-2 was increased in the control group. 
However, there were no significant differences between 
the two groups. IL-2 is a pro-inflammatory cytokine which 
will enhance the inflammatory response. Having decrea-
sed level of IL-2 could be explained by the poor micro-
circulation of blood.  
Traumatic tooth loss always causes problems and is 
inconvenient and frustrating to patients. For example, it 
directly affects chewing, cutting of food, and pronuncia-
tions. Besides, it also affects one’s physical appearance. 
The current methods to restore missing teeth include 
removable dentures, tooth-supported, and implant-
retained provisional restorations (Shernoff et al., 1994; 
Cho et al., 2007). Each method has its own pros and 
cons. Placing dental implants, compared to other teeth 
restorative methods, will eliminate the discomfort of 
removable dentures and will make chewing easier than 
dentures, as sliding of dentures make chewing difficult 
(Wolfinger and Balshi, 2002). Furthermore, because adja-
cent natural teeth are not altered to support the implant, 
more teeth will remain intact. In contrast, as dental 
implant involves osseointegration, it may cause rejection, 
inflammation and allergic response to metal-sensitive 
patients (Stejskal et al., 2006). As indicated by other 
studies, patients with uncontrolled chronic disease, such 
as diabetes and heart disease, are contraindicated to 
dental implants (Fonseca, 2007; Bianchi et al., 2008).  
The reduced success rate of multiple implants in 
adjacent edentulous space in diabetic patients was 
mainly due to the large masticatory force. Normally, when 
one implant is integrated into bone, the force during mas-
tication is dispersed to the surrounding healthy teeth. 
However, if multiple implants are integrated into the same 
edentulous space, little force during mastication is dis-
persed to the healthy teeth. Instead, this force acts on 
implants because of the edentulous space. It increases 
the mobility of implants, loosens the implants and even-
tually they fail to anchor to bone. Besides the force that 
acts on the implants, the process of healing also leads to 
a lower success rate in multiple implants in an edentulous 
space. In addition to the slow healing process of diabetic 
patients, multiple implants in an edentulous space crea-
tes a larger wound, which will further lengthen the time 
for healing and increase the risk of infection due to patho-
genic bacteria surrounding the incision.  
In conclusion, diabetes mellitus had a less success rate 
on dental implants and this method of restoration slightly 
triggered inflammation to diabetes mellitus patients. 
Therefore, the larger the number of implants placed adja-
cent to each other in an edentulous space in these 
patients, the more likely they will fail because the wound 
is much larger. Further investigation should be done on 
the control of blood glucose level to improve success rate 
of dental implants on diabetes mellitus patients. 
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